Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
55,295,141
-
Shares change
-
+7,664,963
-
Total reported value, excl. options
-
$428,707,093
-
Value change
-
+$59,837,958
-
Put/Call ratio
-
1.47%
-
Number of buys
-
53
-
Number of sells
-
-31
-
Price
-
$7.75
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2017
105 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q3 2017.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,295,141 shares
of 334,352,960 outstanding shares and own 16.54% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6,425,626 shares), FRANKLIN RESOURCES INC (5,205,291 shares), PERCEPTIVE ADVISORS LLC (4,726,114 shares), BlackRock Inc. (4,463,098 shares), venBio Select Advisor LLC (4,201,343 shares), ACUTA CAPITAL PARTNERS, LLC (3,431,809 shares), VICTORY CAPITAL MANAGEMENT INC (2,638,323 shares), VANGUARD GROUP INC (2,506,839 shares), Broadfin Capital, LLC (2,487,622 shares), and FRAZIER MANAGEMENT LLC (2,188,331 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.